BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10326165)

  • 1. Heart failure therapy: not as complicated as it looks.
    Mills RM; Young JB
    Clin Cardiol; 1999 May; 22(5):333. PubMed ID: 10326165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Congestive heart failure, part 2: treatment].
    Smith JG; Kohl S; Kornhall B; Ekmehag B
    Lakartidningen; 2012 Oct 10-16; 109(41):1829-34. PubMed ID: 23173405
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic heart failure].
    Nowak B
    MMW Fortschr Med; 2013 Nov; 155 Spec No 2():76-80; quiz 81. PubMed ID: 24734463
    [No Abstract]   [Full Text] [Related]  

  • 4. The Year in Cardiology 2012: heart failure.
    McDonagh TA
    Eur Heart J; 2013 Feb; 34(7):499-502. PubMed ID: 23321348
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic systolic heart failure].
    Hasenfuse G; Anker SD
    Dtsch Med Wochenschr; 2013 Aug; 138(31-32):1556. PubMed ID: 23884736
    [No Abstract]   [Full Text] [Related]  

  • 6. MY APPROACH to treating heart failure with reduced ejection fraction.
    Greenberg BH
    Trends Cardiovasc Med; 2014 Nov; 24(8):367-8. PubMed ID: 25267506
    [No Abstract]   [Full Text] [Related]  

  • 7. Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
    Cleland JG; Ghosh J; Freemantle N
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):10-1. PubMed ID: 16265249
    [No Abstract]   [Full Text] [Related]  

  • 8. The year in cardiology: heart failure 2014.
    Voors AA; Ruschitzka F
    Eur Heart J; 2015 Feb; 36(7):421-4. PubMed ID: 25575601
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapies for heart failure: a report from the Heart Failure Congress 2007.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E16. PubMed ID: 18297144
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
    Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
    JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of heart failure].
    Jourdain P
    Soins; 2013 Apr; (774):29-34. PubMed ID: 23697056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].
    Mundhenke M
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2297-8; author reply 2298. PubMed ID: 17036279
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies.
    Swedberg K
    Eur J Heart Fail; 2000 Sep; 2(3):229-33. PubMed ID: 10938480
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heart failure. 2: Therapy].
    Morf S; Hochuli M; Elke B; Noll G
    Praxis (Bern 1994); 2010 Jan; 99(2):83-91; quiz 92-3. PubMed ID: 20087825
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical therapy in adults with congenital heart disease.
    Book WM; Shaddy RE
    Heart Fail Clin; 2014 Jan; 10(1):167-78. PubMed ID: 24275302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine and outcomes in chronic heart failure.
    Gupta A; Sharma YP
    Lancet; 2010 Dec; 376(9758):2069; author reply 2069-70. PubMed ID: 21168044
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological ventricular remodeling: therapies: part 2 of 2.
    Xie M; Burchfield JS; Hill JA
    Circulation; 2013 Aug; 128(9):1021-30. PubMed ID: 23979628
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adult congenital heart disease associated with heart failure].
    Tomimatsu H; Toyoda T
    Nihon Rinsho; 2007 May; 65 Suppl 5():527-30. PubMed ID: 17569326
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
    van der Horst IC; Voors AA; van Veldhuisen DJ
    Clin Res Cardiol; 2007 Apr; 96(4):193-5. PubMed ID: 17294352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.